Your browser doesn't support javascript.
loading
Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS).
Bettinger, D; Schultheiss, M; Boettler, T; Muljono, M; Thimme, R; Rössle, M.
Afiliação
  • Bettinger D; Department of Medicine II, University Hospital Freiburg, Freiburg, Germany. dominik.bettinger@uniklinik-freiburg.de.
  • Schultheiss M; Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
  • Boettler T; Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
  • Muljono M; Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
  • Thimme R; Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
  • Rössle M; PraxisZentrum für Gastroenterologie und Endokrinologie, Freiburg, Germany.
Aliment Pharmacol Ther ; 44(10): 1051-1061, 2016 11.
Article em En | MEDLINE | ID: mdl-27670147
ABSTRACT

BACKGROUND:

The implantation of a transjugular intrahepatic portosystemic shunt (TIPSS) is a complex angiographic procedure performed in patients with end-stage liver disease. Numerous case reports and narrative reviews have been published so far; however, studies systematically investigating procedural and shunt-related complications are lacking.

AIM:

To systematically investigate complications and mortality occurring during the index hospital stay and the early (4-week) period after TIPSS implantation.

METHODS:

The study includes 389 patients who received a TIPSS implantation between 2004 and 2014. Data were obtained from the clinical records and technical reports of the TIPSS implantation.

RESULTS:

During the index hospital stay, procedure-related complications occurred in 42 patients (10.8%) with intraperitoneal bleeding in 8 patients (2.1%) and infections in 14 patients (3.6%). Shunt- and disease-related complications consisted of hepatic encephalopathy (1-year incidence 29%), non-procedural infections (8.7%) and acute hepatic decompensation (4.1%). Nine patients (2.3%) died during the index hospital stay from procedure-related (two patients, 0.5%), shunt-related (four patients, 1%) or disease-related causes (three patients, 0.8%). 23 patients (5.9%) died during 4 weeks after TIPSS implantation. The 1-year probability of survival was 67.7% and was negatively associated with severe hepatic encephalopathy and acute hepatic decompensation.

CONCLUSIONS:

Except hepatic encephalopathy, severe procedure- and shunt-related complications are rare and early mortality is low.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Derivação Portossistêmica Transjugular Intra-Hepática / Doença Hepática Terminal Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Derivação Portossistêmica Transjugular Intra-Hepática / Doença Hepática Terminal Idioma: En Ano de publicação: 2016 Tipo de documento: Article